The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients With SLE Prone to Infections

Cell Reports - United States
doi 10.1016/j.celrep.2019.12.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

CD38-NAD + Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2018English

Primary Cutaneous CD8 Aggressive Epidermotropic Cytotoxic T Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2020English

Multiplex Screening Assay for Identifying Cytotoxic CD8+ T Cell Epitopes

Frontiers in Immunology
AllergyImmunology
2020English

Signalling via T Cell Receptor (TCR) in Patients With SLE

Arthritis Research & Therapy
2001English

CD8+ Epidermotropic Cytotoxic T-Cell Lymphoma With Peripheral Blood and Central Nervous System Involvement

Archives of Dermatology
2008English

CD38 Bright Effector Memory CD8+ T Cell Populations Predict Acute Graft Versus Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Peptide Vaccination Elicits Leukemia-Associated Antigen-Specific Cytotoxic CD8+ T-Cell Responses in Patients With Chronic Lymphocytic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Timing of CD8 T Cell Effector Responses in Viral Infections

Royal Society Open Science
Multidisciplinary
2016English

Cimetidine Synergizes With Praziquantel to Enhance the Immune Response of HBV DNA Vaccine via Activating Cytotoxic CD8+ T Cell

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy